Pentoxifylline reduces alveolar capillary membrane injury and subsequent protein leakage and improves cardiac output when administered after 30 minutes of intestinal ischemia. These data suggest that pentoxifylline may be a possible candidate as a future therapy for acute pulmonary dysfunction. Further studies in human patients are necessary.
Vera BrodDan WaismanA. RotschildZalman WeintraubHaim Bitterman
Masashi KishiH. L. TanakaAkitoshi SeiyamaMakoto TakaokaTetsuya MatsuokaToshiharu YoshiokaHisashi Sugimoto
Carlos Eduardo MarquiHelga Cristina Almeida da SilvaDavid FerezSâmia Santos CavassaniJuliana Britto MoraesDanielle A. M. da SilvaRicardo Santos SimõesCaroline Aparecida LopesMurched Omar TahaItamar Souza de Oliveira-Júnior
Mary B. CarterMark WilsonWilliam B. WeadR. Neal Garrison